Regulation of receptor fate by ubiquitination of activated β2-adrenergic receptor and β-arrestin

被引:675
作者
Shenoy, SK
McDonald, PH
Kohout, TA
Lefkowitz, RJ
机构
[1] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
[3] Duke Univ, Med Ctr, Dept Cardiol, Durham, NC 27710 USA
[4] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA
关键词
D O I
10.1126/science.1063866
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Although trafficking and degradation of several membrane proteins are regulated by ubiquitination catalyzed by E3 ubiquitin ligases, there has been little evidence connecting ubiquitination with regulation of mammalian G protein (heterotrimeric guanine nucleotide-binding protein)-coupled receptor (GPCR) function. Agonist stimulation of endogenous or transfected beta (2)-adrenergic receptors (beta (2)ARs) led to rapid ubiquitination of both the receptors and the receptor regulatory protein, beta -arrestin. Moreover, proteasome inhibitors reduced receptor internalization and degradation, thus implicating a role for the ubiquitination machinery in the trafficking of the beta (2)AR. Receptor ubiquitination required beta -arrestin, which bound to the E3 ubiquitin ligase Mdm2. Abrogation of beta -arrestin ubiquitination, either by expression in Mdm2-null cells or by dominant-negative forms of Mdm2 lacking E3 ligase activity, inhibited receptor internalization with marginal effects on receptor degradation. However, a beta (2)AR mutant tacking lysine residues, which was not ubiquitinated, was internalized normally but was degraded ineffectively. These findings delineate an adapter role of beta -arrestin in mediating the ubiquitination of the beta (2)AR and indicate that ubiquitination of the receptor and of beta -arrestin have distinct and obligatory roles in the trafficking and degradation of this prototypic GPCR.
引用
收藏
页码:1307 / 1313
页数:7
相关论文
共 25 条
  • [1] Ubiquitin and the control of protein fate in the secretory and endocytic pathways
    Bonifacino, JS
    Weissman, AM
    [J]. ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 1998, 14 : 19 - 57
  • [2] BOUVIER M, 1988, MOL PHARMACOL, V33, P133
  • [3] RETRACTED: SUMO-1 modification of Mdm2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53 (Retracted Article)
    Buschmann, T
    Fuchs, SY
    Lee, CG
    Pan, ZQ
    Ronai, Z
    [J]. CELL, 2000, 101 (07) : 753 - 762
  • [4] Proteasome involvement in agonist-induced down-regulation of μ and δ opioid receptors
    Chaturvedi, K
    Bandari, P
    Chinen, N
    Howells, RD
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (15) : 12345 - 12355
  • [5] MAPPING OF THE P53 AND MDM-2 INTERACTION DOMAINS
    CHEN, JD
    MARECHAL, V
    LEVINE, AJ
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (07) : 4107 - 4114
  • [6] THE 2-HYBRID SYSTEM - A METHOD TO IDENTIFY AND CLONE GENES FOR PROTEINS THAT INTERACT WITH A PROTEIN OF INTEREST
    CHIEN, CT
    BARTEL, PL
    STERNGLANZ, R
    FIELDS, S
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (21) : 9578 - 9582
  • [7] Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53
    Fang, SY
    Jensen, JP
    Ludwig, RL
    Vousden, KH
    Weissman, AM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (12) : 8945 - 8951
  • [8] beta-arrestin acts as a clathrin adaptor in endocytosis of the beta(2)-adrenergic receptor
    Goodman, OB
    Krupnick, JG
    Santini, F
    Gurevich, VV
    Penn, RB
    Gagnon, AW
    Keen, JH
    Benovic, JL
    [J]. NATURE, 1996, 383 (6599) : 447 - 450
  • [9] A SMALL REGION OF THE BETA-ADRENERGIC-RECEPTOR IS SELECTIVELY INVOLVED IN ITS RAPID REGULATION
    HAUSDORFF, WP
    CAMPBELL, PT
    OSTROWSKI, J
    YU, SS
    CARON, MG
    LEFKOWITZ, RJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (08) : 2979 - 2983
  • [10] The ubiquitin system
    Hershko, A
    Ciechanover, A
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1998, 67 : 425 - 479